Skip to content
Return home Capuano IP
  • Home
  • About
    • About Our Firm
    • About Vincent L. Capuano, PH.D.
  • Services
    • Chemical Sciences
    • Pharmaceutical Patents
    • Trade Secret Protection
    • Patent Litigation
    • Hatch-Waxman Act
    • Biosimilars
  • Experience
    • Litigation Experience
    • Our Track Record
  • News & Publications
  • Blog
  • Contact
703.992.4580 VLC@capuanoip.com

Archives: Publications

Return home Publications
Licensing Executives Society

Speaker, “Biosimilars and Follow-On Biologics,”

Inorganica Chimica Acta, 204(1): 93-101 (1993);

Orthogonal RuII(bpy)3 Complexes in Meso-Substituted Porphyrins

JL Sessler, VL Capuano and AK Burrell
in Photoprocesses in Transition Metal Complexes, Biosystems and Other Molecules. Experiment and Theory, 375-401 (1992);

Examining Long-Distance Electron Transfer with Synthetic Model Systems

JL Sessler, VL Capuano, Y Kubota, MR Johnson, D Magda and AH Harriman
Tetrahedron Letters, 34(14): 2287-2290 (1993);

Selective Insertion of Ni(II) into the Outer Porphyrin Subunits of a Trimeric Porphyrin Array

Angewandte Chemie, 102(10): 1162-1164 (1990); Int. Ed. Engl., 29(10): 1134-1137 (1990);

Phenyl-Linked Quinone-Substituted Porphyrin Trimers,

JL Sessler and VL Capuano
J. Am. Chem. Soc., 115(11): 4618-4628 (1993);

Electronic Energy Migration and Trapping in Quinone-Substituted, Phenyl-Linked Dimeric and Trimeric Porphyrins

JL Sessler, VL Capuano and A Harriman
CBI’s 3rd Annual Life Sciences Congress on Paragraph IV Disputes

Speaker “Pre-Litigation Strategy, Analysis and Preparation for PIV Disputes,”

Duane Morris LLP (Linked-In)

Cannabis Patent Review II: Patented (and Unapproved) Therapeutic Uses for CBD

Vincent Capuano, Ph.D.
Duane Morris LLP (Linked-In)

Cannabis Patent Review I: Extraction and Purification

Vincent Capuano, Ph.D.
AP News

Quoted in “How much pot in that brownie? Chocolate can throw off tests,”

Posts navigation

Older posts
Contact Us Online

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.
Recent Posts
  • Federal Circuit Refuses to Consider Disease Variants as Species of a Disease Genus for Method of Treatment Patents
  • A Proposal to Address the U.S. Patent “Thicket” Problem During Examination
  • Capuano IP Launches New Website
  • Alnylam Pharms, Inc. v. Dicerna Pharms, Inc. (15-04126-EPL) (Mass. Sup. Ct.)
Our Office
120 Washington St.
Salem, MA 01970
Call Menu Contact
Capuano IP
© 2025 Capuano Law | Attorney Advertising | Disclaimer
Website Development by Omnizant - View site in new window
Navigate
Home Services About Experience Media Contact
Reach Out
703.992.4580
120 Washington St.
Salem, MA 01970
Salem, MA
VLC@capuanoip.com
Follow Us
View our firm profile on LinkedIn, opens in a new window
Call Our Firm
Main Office
Call our office 703.992.4580
Cell
Call our office
Attorney Advertising | Disclaimer | Privacy Policy
Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 703.992.4580
Return home Capuano IP
703.992.4580 VLC@capuanoip.com
  • Home
  • About
    • About Our Firm
    • About Vincent L. Capuano, PH.D.
  • Services
    • Chemical Sciences
    • Pharmaceutical Patents
    • Trade Secret Protection
    • Patent Litigation
    • Hatch-Waxman Act
    • Biosimilars
  • Experience
    • Litigation Experience
    • Our Track Record
  • News & Publications
  • Blog
  • Contact
Close Menu
  • Home
  • About
    • About Our Firm
    • About Vincent L. Capuano, PH.D.
  • Services
    • Chemical Sciences
    • Pharmaceutical Patents
    • Trade Secret Protection
    • Patent Litigation
    • Hatch-Waxman Act
    • Biosimilars
  • Experience
    • Litigation Experience
    • Our Track Record
  • News & Publications
  • Blog
  • Contact